APOHEALTH SORE THROAT LOZENGES PLUS ANAESTHETIC blister pack

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

lidocaine hydrochloride monohydrate, Quantity: 4 mg; benzydamine hydrochloride, Quantity: 3 mg; dichlorobenzyl alcohol, Quantity: 1.2 mg

Commercializzato da:

Nova Pharmaceuticals Australasia Pty Ltd

INN (Nome Internazionale):

Benzydamine hydrochloride,Dichlorobenzyl alcohol,lidocaine (lignocaine) hydrochloride monohydrate

Forma farmaceutica:

Lozenge

Composizione:

Excipient Ingredients: quinoline yellow; purified water; sucralose; isomalt; menthol; citric acid; ethanol absolute; Flavour

Via di somministrazione:

Oromucosal

Confezione:

12, 16, 24, 32, 36, 48

Tipo di ricetta:

Not Scheduled after consideration by Committee

Indicazioni terapeutiche:

For the relief of major symptoms associated with sore throat. Reduces inflammation and relieves pain for fast effective relief of symptoms of a sore throat, oral surgery, minor mouth infections and dental procedures.

Dettagli prodotto:

Visual Identification: A yellow coloured, round, flat bevelled lozenges.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Stato dell'autorizzazione:

Licence status A

Data dell'autorizzazione:

2017-04-26